The present investigation used an antibody directed against the extracellular domain of the signal transducing nerve growth factor receptor, trkA, to reveal immunoreactive perikarya or fibers within the olfactory bulb and tubercle, cingulate cortex, nucleus accumbens, striatum, endopiriform nucleus, septal/ diagonal band complex, nucleus basalis, hippocampal complex, thalamic paraventricular and reuniens nuclei, periventricular hypothalamus, interpeduncular nucleus, mesencephalic nucleus of the fifth nerve, dorsal nucleus of the lateral lemniscus, prepositus hypoglossal nucleus, ventral cochlear nucleus, ventral lateral tegmentum, medial vestibular nucleus, spinal trigeminal nucleus oralis, nucleus of the solitary tract, raphe nuclei, and spinal cord. Colocalization experiments revealed that virtually all striatal trkAimmunoreactive neurons ( > 99%) coexpressed choline acetyltransferase ( C U T ) but not p75 nerve growth factor receptor (NGFR). Within the septal/diagonal band complex virtually all trkA neurons (> 95%) coexpressed both ChAT and p75 NGFR. More caudally, dual stained sections revealed numerous trkA/ChAT ( > 80%) and trkA/p75 NGFR ( > 95%) immunoreactive neurons within the nucleus basalis. In the brainstem, raphe serotonergic neurons (45%) coexpressed trkA. Sections stained with a pan-trk antibody that recognizes primarily trkA, as well as trkB and trkC, labeled neurons within all of these regions as well as within the hypothalamic arcuate, supramammilary, and supraoptic nuclei, hippocampus, inferior and superior colliculus, substantia nigra, ventral tegmental area of T'sai, and cerebellar Purkinje cells. Virtually all of these other regions with the exception of the cerebellum also expressed pan-trk immunoreactivity in the monkey. The widespread expression of trkA throughout the central neural axis suggests that this receptor may play a role in signal transduction mechanisms linked to NGF-related substances in cholinergic basal forebrain and noncholinergic systems. These findings suggest that pharmacological use of ligands for trkA could have beneficial effects on the multiple neuronal systems that are affected in such disorders as Alzheimer's disease.
within the central nervous system (CNS) was first identified in the adult rat brain following injection of radiolabeled NGF into the cortex and hippocampus. These investigations did not reveal retrogradely labeled perikarya within the noradrenergic locus coeruleus as expected, but instead exclusively labeled neurons within the septalidiagonal band complex and the nucleus basalis magnocellularis (Schwab et al., 1979; Seiler and Schwab, 1984) . These transport studies, combined with additional converging lines of evidence, indicate that NGF modulates the development, survival, and maintenance of cholinergic basal forebrain neurons. NGF levels are, for instance, found in highest concentrations within basal forebrain neuron target regions such as the cerebral cortex, hippocampus, and olfactory bulb (e.g., Whittemore et al., 1986; Large et al., 1986) . Autoradiographic investigations have shown that neurons which bind radiolabeled NGF codistribute with basal forebrain cholinergic neurons (Richardson et al., 1986; Raivich and Kreutzberg, 1987) . Furthermore, immunohistochemical and in situ hybridization studies in rats (Yan and Johnson, 1988; Batchelor et al., 1989; Koh et al., 19891, monkeys (Kordower et al., 19881 , and humans Hefti and Mash, 1989; Higgins and Mufson, 1989; Kordower et al., 1989a,b; Mufson et al., 1989) have demonstrated a high degree of codistribution and colocalization between the low-affinity p75 NGF receptor (NGFR) and the specific cholinergic marker, choline acetyltransferase (CUT). Recently, NGF immunoreactivity also has been found within the cholinergic basal forebrain (CBF) neurons of rats Conner et al., 19921 , monkeys, and humans .
Functionally, NGF has neurotrophic effects upon CBF neurons both in vitro and in vivo (see Hefti et al., 1989) . In this regard, NGF increases ChAT activity and enhances T. SOBREVIELA ET AL.
neurite outgrowth of septal neurons in culture (Hefti et al., 1989) . In vivo, intraventricular administration of NGF reverses the age-related atrophy of cholinergic basal forebrain neurons (Fischer et al., 1987) and prevents the degeneration of cholinergic septalidiagonal band neurons following fimbria fornix transection in rats (Williams et al., 1986; Kromer, 1987; Hefti et al., 1989 ) and nonhuman primates (Koliatsos et al., 1990; Tuszynski et al., 1991) .
Similarly, intracerebral grafts of NGF-secreting cells can rescue axotomized basal forebrain neurons in rodents (Rosenberg et al., 1988; Kawaja et al., 1992; Winn et al., 1994) and young (Emerich et al., in press) and aged nonhuman primates and in press a and b.
NGF is one member of a superfamily of neurotrophins which includes brain-derived neurotrophic factor (BDNF; e.g., Hohn et al., 19901, neurotrophin-3 (NT-3; e.g., Maisonpierre et al., 1990) , and neurotrophin-4i5 (NT-415; e.g., Ip et al., 1993; Berkmeier et al., 1991) . These neurotrophins all share significant structural homology and some overlapping functional effects. Although regions of nonidentity confer neurotrophin specificity, each binds to the lowaffinity p75 NGFR (Chao et al., 1986; Bothwell, 1991; Ebendal, 1992) . While the p75 NGFR may, in some instances, play a functional role in neurotrophin activity (e.g., Hempstead et al., 19891 , signal transduction appears to require an interaction with a distinct tyrosine kinase (trk) receptor (see review: Parada et al., 1992) . NGF binding stimulates the tyrosine kinase activity of trkA (Bothwell, 1991; Kaplan et al., 1991; Klein et al., 1991; Ebendal, 1992; Jing et al., 1992; Parada et al., 1992) . Inactivation, removal, or functional inhibition of the tyrosine kinase domain (Ferrari et al., 1992; Jing et al., 1992; Knusel and Hefti, 1992; Nye et al., 1992; Ohmichi et al., 1992; Tapley et al., 1992) precise CNS cell groups containing trkA is not clearly defined, it is known that cholinergic neurons of the striatum and basal forebrain express trkA mRNA (Lu et al., 1989; Kokaia et al., 1993; Miranda et al., 1993) and protein (Steininger et al., 1993) . A recent in situ hybridization study revealed a more widespread distribution for trkA message throughout the rat CNS including many non-basal forebrain cholinergic cell groups (Gibbs and Pfaff, 1994) . However, there are no systematic immunocytochemical investigations of the distribution of trkA protein containing neurons and fibers and their relation to neurotransmitters other than choline acetyltransferase (Steininger et al., 1993) .
Therefore, the purpose of the present study was to utilize a polyclonal antibody, directed against the rat extracellular domain of the trkA receptor (RTA; Clary et al., 19941 , to characterize the distribution of this signal transducing receptor throughout the adult rat CNS. Dual immunohistochemical staining procedures were used to assess the extent to which trkA-immunoreactive (ir) neurons colocalized with choline acetyltransferase in the basal forebrain and serotonin in the brainstem raphe nuclear complex. Moreover, the immunohistochemical distribution of the trkA protein was compared to that seen using an antibody directed against the low-affinity p75 NGFR and a pan-trk antisera which primarily recognizes trkA (Steininger et al., 1993; Kordower et al., in press ), although it potentially displays some crossreactivity with trkB and trkC. Finally, we compared the distribution of the trkA protein seen within the rodent and monkey brainstem and spinal cord.
MATERIALS AND METHODS Subjects
Adult male Sprague-Dawley rats (Harlan, Indianapolis, IN; weighing 250-300 g; n = 6) were housed one per cage at 20°C on a 12:12-hour light-dark cycle. Food and water were available ad libitum. Tissue from the brainstem and spinal cord of three New World Cebus apella monkeys and three Macaca mulatta monkeys of both genders were also examined. These animals were part of a previously reported investigation of trk immunostaining within the forebrain and in press a and b. All animal related procedures were conducted in strict compliance with approved institutional animal care protocols and in accordance with NIH guidelines (Guide for the Care and Use of Laboratory Animals, NIH publication No. 86-23, 1985).
Tissue preparation
Each rat was anesthetized with sodium pentobarbital (25 mg/kgbody weight, i.p.), perfused transcardially with 0.1 M phosphate-buffered saline (PBS) followed by 250 ml of 4% paraformaldehyde in phosphate buffer (pH 7.41, and cryoprotected in 30% sucrose/PBS. Prior to killing, monkeys were pretreated with ketamine (10 mgikg, i.m.) and then deeply anesthetized with sodium pentobarbital (25 mg/kg, i.v.1. Prior to perfusion, monkeys were injected with 1 ml of heparin (20,000 IU) into the left ventricle of the heart. Each animal was then perfused transcardially with 0.9% saline and 4% paraformaldehyde. For both rats and monkeys, the brains were removed from the calvaria and cryoprotected in 30% sucrose in 0.1 M phosphate buffer at 4°C. All brains were cut frozen at 40 km thickness on a sliding knife microtome and stored at 0°C in a cryoprotectant solution prior to processing.
Antibodies
A series of sections from each rat brain and spinal cord was processed for the visualization of the rat trkA receptor. The production and specificity of this antibody (RTA) has been described previously (Clary et al., 1994) . Briefly, a polyclonal antiserum was prepared that recognizes the extracellular domain of the trkA receptor. A truncated portion of the full-length rat trkA coding sequence containing the extracellular domain was generated by polymerase chain reaction. The expression cassette directed production of a truncated trkA protein in baculovirus-infected Spodopteru frugiperdu cells. The RTA antibody does not recognize either trkB or trkC (Clary et al., 1994) . The RTA antibody was used at a dilution of 1:10,000 in the present study. Adjacent sections were immunohistochemically stained with a pan-trk antibody (1500; polyclonal rabbit anti-trk; Oncogene Science Inc., Cambridge, MA), which is directed against the 77-90 amino acid sequence of the trk protein and crossreacts principally, although not exclusively, with the trkA receptor (Steininger et al., 1993; Kordower et al., 1994 and in press a and b). Additional sections were processed for the low-affinity p75 NGFR receptor (1:5,000; monoclonal mouse anti-p75 NGFR; Oncogene Science Inc., Cambridge, MA), choline acetyltransferase (1230; ChAT; monoclonal mouse anti-ChAT; Boehringer Mannheim Corporation, Indianapolis, IN), and serotonin (1: 10,000; polyclonal goat anti-serotonin; IncStar, Stillwater, MN). Additionally, selected trkA-immunostained sections were concurrently immunolabeled for p75 NGFR, and ChAT or serotonin.
Immunohistochemistry
Immunohistochemistry was carried out according to a modification of a previously reported procedure (Kordower et al., 1989a,b; Mufson et al., 1989 Mufson et al., , 1993a . Briefly, following several rinses in Tris-buffered saline solution (TBS), tissue sections were incubated for 20 minutes in a TBS solution containing 0.1 m sodium periodate to inhibit endogenous peroxidase activity. After three rinses in TBS with 0.25% Triton X-100 (TBS-Tx), sections were soaked for 1 hour in a TBS-Tx and 10% normal blocking serum (goat serum for trkA and pan-trk; horse serum for p75 NGFR, CUT, and serotonin) and 2% bovine serum albumin. After decanting the blocking solution, the primary antibody at the appropriate dilution (see above) was applied for 24 hours at room temperature with constant agitation in a medium containing 0.4% Triton X-100 and 3% blocking serum. After decanting the primary antibody solution and washing the tissue (3 x 10 minutes), sections were incubated in a 1500 dilution of biotinylated IgG secondary anti-serum (goat anti-rabbit for trkA and pan-trk; horse anti-mouse for C U T ; horse anti-goat for serotonin; Vector Laboratories) for 1 hour. Following 3 x 10-minute rinses, processed sections were incubated for 60 minutes in an avidin-biotin complex ("Elite Kit," Vector Laboratories; 1:200). Sections were washed (3 x 10 minutes) in a 0.2 M sodium acetate, 1.0 M imidazole buffer (pH 7.4). The chromogen solution which completed the reaction consisted of 2.5% nickel I1 sulfate (Fisher), 0.05% 3,3' diaminobenzidine (DAB), and 0.005% H202 mixed in this buffer. The reaction was terminated with washes in acetate-imidazole buffer. Sections were mounted on gelatin-coated slides, dehydrated through graded alcohols (70%, 95%, loo%), cleared in xylenes, and coverslipped with Permount. Additional sections were stained with cresyl violet acetate (1% in HzO, pH 3.3) for the demonstration of Nissl substance.
Double-immunohistochemical staining procedure
We used a previously described dual-immunohistochemical procedure (Levey et al., 1986; Mufson et al., 1991a; Benzing et al., 1993) to determine whether trkA-ir neurons within the basal forebrain and brainstem raphe colocalized with cholinergic ( C U T and p75 NGFR) and serotonergic neurons, respectively. The immunohistochemical protocol described above was employed with the exception that DAB (brown reaction product) was used as the first chromogen to visualize trkA-containing neurons followed either by antisera directed against C U T or p75 NGFR. In each case benzidine dihydrochloride (BDHC) was used as the second chromogen which produces a granular dark blue reaction product. The order of antigen presentation was reversed for the dual localization of serotonin and trkA. This dual procedure allows easy visual discrimination of colocalized antigens within the same neurons (Levey et al., 1986; Mufson et al., 1991a; Benzing et al., 1993) . Tissue sections processed for dual immunohistochemistry with BDHC were dehydrated quickly through graded alcohols and covered with Permount.
Immunohistochemieal controls
Control sections were processed in a manner identical with that described above except that the primary antibody was deleted or an irrelevant IgG matched for protein concentration was substituted for the primary antibody. In the colocalization experiments, for the control sections the tissue was processed in an identical manner as described above except that the antibody solvent or irrelevant I& was substituted in place of either the first or second primary antibody. It should be noted that the specificity for trkA, pan-trk, NGFR, ChAT, or serotonin (or other antigens) is not absolute. Therefore, the potential for antisera to crossreact with other structurally related proteins cannot be excluded. Because of this caution, which is inherent to any immunohistochemical procedure, the term immunohistochemical reaction (or -immunoreactivity, -ir) in this study refers to "-like" immunoreactivity. As an additional control, experiments were carried out in which the pan-trk antibody was preadsorbed with a tenfold excess of the pan-trk peptide (Oncogene Inc.) for 48 hours prior to tissue incubation (for details, see Kordower et al., 1994 and in press a and b).
Data analysis
The distribution of the trkA-ir perikarya and fibers as well as cell counts of single versus double immunopositive neurons was evaluated with the aid of a Hewlett-Packard X-Y plotter interfaced with an IBM driven Microplotter 4000+ computer system (Dilog Instruments, Tallahassee, FL) coupled to the mechanical stage of a Nikon microscope. Data analysis was performed under brightfield and darkfield illumination. The terminology used for structures of the rat brain was derived from the atlas of Paxinos and Watson (1986) .
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RESULTS

General characteristics
TrkA-ir cell bodies and fibers appeared dark blue-black throughout the rodent CNS when reacted with nickel intensification. TrkA-ir neurons typically displayed bipolar and multipolar morphological phenotypes within different brain regions (Figs. 1-6 ). Neuronal trkA-ir was located mainly in the cytoplasm. Single-labeled sections immunohistochemically stained for trkA revealed positive neurons within the olfactory tubercle, nucleus accumbens, striatum, basal forebrain subfields (Chl-Ch4; Mesulam et al., 1983) , thalamus, hypothalamus, and brainstem (Figs. 1-7) . TrkA-ir fibers were found scattered in many of these regions as well as within the cortex, hippocampus, and spinal cord . Dual-labeled experiments colocalizing ChAT and trkA revealed a concordance of these proteins within striatal ( > 99%) and magnocellular basal forebrain complex neurons (80-95%). In contrast, sections dual stained for trkA and p75 NGFR revealed a virtually 100% colocalization only within the basal forebrain cholinergic neurons. In the brainstem we observed a subpopulation of serotonergic raphe neurons (45%) colocalized with trkA. Control sections incubated in the vehicle solution, an irrelevant IgG, or with preadsorbed antisera in lieu of the primary antibody did not display either trkA, pan-trk, C U T , p75 NGFR, or serotonin immunoreactivity. Dual-immunostained sections in which one primary antibody was omitted revealed staining for only the appropriate antigens.
TrkA-immunoreactive neurons within rat telencephalon
In the telencephalon, trkA-ir neurons were observed in the olfactory tubercle, nucleus accumbens, striatum, and basal forebrain subfields (Figs. 1-4, 7; Table 1 ). The neuropil of the olfactory tubercle was stained intensely €or trkA (Fig. 1) . Numerous trkA-ir neurons were scattered within this region with a preponderance of immunostained perikarya located in its more dorsal aspect. The morphology of trkA-ir neurons within the olfactory tubercle was bipolar and multipolar (85-208 km2) . The nucleus accumbens exhibited several trkA-ir neurons mainly within its more medial aspect. Numerous trkA-ir neurons were also seen scattered throughout the striatum. The distribution and morphology of trkA-ir neurons within the striatum was similar to that seen for ChAT, and these proteins colocalized greater than 99% within this structure (Fig. 13A) . Striatal trkA-ir neurons were medium sized (186-280 km2) with short neurites extending from the cell soma and exhibiting the morphology indicative of interneurons (Figs.  2, 13A ). TrkA-ir within the striatum gave rise to modest neuropil staining. A patch-matrix organization of trkA-ir was not evident.
Proceeding caudally, a continuum of trkA-ir neurons was seen extending throughout the subfields of the rodent basal forebrain (Table 1 ). Large and medium-sized trkA-ir neurons (129-268 pm2) were seen within the medial septum and diagonal band complex (Figs. 3, 4, 7) . These cells were located along the midline and paramidline within the septum. Ventrally, numerous large magnocellular trkA-ir neurons (161-323 Fm2) were seen within the vertical limb of the diagonal band (Figs. 3, 7) . More caudally, trkA-ir neurons were found within the horizontal limb of the diagonal band (Figs. 4C,D, 7) . At this level, numerous magnocellular trkA-ir perikarya were also observed scattered within the rodent nucleus basalis (Figs. 4A,B, 7) . Clusters of these cells were embedded within the internal capsule and a few were dispersed within the ventral portion of the globus pallidus. Morphologically these neurons appeared mainly as large multipolar perikarya (64-263 ym2) exhibiting either triangular or fusiform shapes with long neurites emanating from the soma. No trkA-ir neuronal cell somata were detected in the hippocampal formation or the amygdala.
TrkA-immunoreactive neurons within the rat diencephalon
Within the diencephalon, both darkly and lightly labeled trkA-ir neurons were found only within the thalamic paraventricular (75-117 ym2; Figs. 5A and 7) and reuniens (93-129 pm2) nuclei (Fig. 7) as well as within the periventricular hypothalamic region ( Fig. 7; Table 1 ). Morphologically the trkA-ir neurons within these nuclei appeared round in shape with a modest dendritic arborization.
TrkA-immunoreactive neurons within the rat mesencephalon
TrkA-ir neurons were seen within the interpeduncular nucleus (40-69 km2), the mesencephalic and oralis portion of the spinal nucleus of the fifth nerve (107-172 km2), and the dorsal nucleus of the lateral lemniscus (127-161 km2) (Fig. 7) . No trkA-ir neurons were seen in the central gray matter, pedunculopontine nucleus, lateral tegmental nucleus, or red nucleus (Table 1) . 
TrkA-immunoreactive neurons within the rat myelencephalon
Many trkA-ir cells were found within the prepositus hypoglossal nucleus (77-147 pm2; Figs. 7, 11) and ventral cochlear nucleus (Figs. 6, 7) . The later region also displayed intense trkA immunoreactivity within the neuropil (Fig. 6) . Several trkA-ir neurons were also seen within the ventral lateral tegmentum, medial vestibular nucleus (98-224 pm2), and raphe nuclei dorsal, median, obscurus, and magnus (98-250 pm2; Figs. 5C, 7, 13G,H), whereas only a very few were seen within the solitarius tract nucleus ( Fig. 7 ; Table 1 ).
TrkA-immunoreactive fibers within the rat central nervous system
A dense accumulation of trkA-ir fibers that formed distinct patches were observed within the glomerular layer of the olfactory bulb (Figs. 7, 8A) . These fibers were mainly seen within the medial aspect of the olfactory bulb. A few fine trkA-ir fibers were found coursing medial to the nucleus accumbens (Figs. 7, 8B ). Other trkA-ir fibers were seen throughout the rostrocaudal extent of the cingulate cortex (Fig. 7) . These fibers were primarily located within layers 3 and 5 . At the level of the septalidiagonal band complex, numerous varicose trkA-ir fibers were seen coursing within this region (Figs. 7, 9A,B) . A few trkA-ir fibers were observed in the lateral aspect of the septum adjacent to the ventricle (Fig. 7) . More laterally, trkA-ir fibers were seen withih the endopiriform nucleus (Figs. 7, 10A ) which did not contain trkA-ir perikarya. These fibers were thick with numerous varicosities. Some trkA-ir fibers were also located veptral to the anterior commissure (Fig. 7) . Dense accumulations of trkA-ir fibers were observed within the diencephalon (Fig. 7) . Numerous beaded trkA-ir fibers were found embedded within the horizontal limb of the diagonal band (Fig. 7,8C ). In the coronal plane, these fibers gave the appearance of a fine particulate scattered throughout this region (Fig. 4C) . Emanating from this fiber plexus was a dorsally directed fascicle which divided into a lateral and TrkA-ir fibers arranged in aloose, disorganized pattern within the hilus of the dentate gyrus of the hippocampus. Note that these fibers do not enter the granular layer of the dentate gyrus (white arrows). Scale bar = 30 pm for A and B. medial bundle. The lateral component traveled within the internal capsule but did not interdigitate with the trkA-ir neurons located within the nucleus basalis (Fig. 7) . The medial component coursed around the fornix enroute to the paratenial and paraventricular midline thalamic nuclei (Fig. 7) . The thalamic paraventricular nucleus contained the heaviest accumulation of trkA-ir fibers within the thalamus. At the level of the lateral hypothalamic area a few trkA-ir fibers were seen within this region (Fig. 7) . Furthermore, numerous trkA-ir fibers were also found distributed within the piriform cortex which were followed toward the amygdaloid complex (Fig. 7) . More caudally, trkA-ir fibers were seen within the hippocampal CA4 field (Figs. 7, 10B ). These fibers were arranged in a loose disorganized pattern within the hilum of the dentate gyrus and for the most part did not enter the granular cell layer of the dentate gyrus. TrkA-ir fibers also innervated CA1 as well as the subicular complex and entorhinal cortex (Fig. 7) . TrkA fibers were observed within the dorsal aspect of the interpenducular nucleus (Figs. 5B, 71 , periaqueductal gray, prepositus hypoglossal nucleus (Figs. 7, 111 , raphe nuclei, and pyramids (Fig. 7) . At all levels of the spinal cord a dense collection of trkA-ir fibers was observed within layers I and I1 of the substantia gelatinosa (Figs. 7, 12) . Only a few lightly immunoreactive trkA fibers were seen within the deeper layers of the spinal cord.
DUAL IMMUNOHISTOCHEMICAL INVESTIGATIONS Colocalization of TrkA/ChAT and p75 NGFR
Colocalization of trkA with either C U T or p75 NGFR immunoreactivity revealed trkA as a brown reaction product and ChAT and p75 NGFR as a granular blue-black precipitate within the neuronal soma, proximal dendrites, and distal processes (Fig. 13A-F) . Table 1 compares regions with colocalization of trkA, C U T , and p75 NGFR. Within (Fig. 13A) . In striatal sections dual stained for trkA and p75 NGFR, only trkA-ir neurons were observed. Occasionally, one or two striatal neurons displayed both trk and p75 NGFR. These cells were located in the ventral medial aspect of the caudal portion of the striatum and may be displaced basal forebrain neurons. Within the septal/diagonal band complex we observed that virtually all t r M neurons (>95%) coexpressed both C U T and p75 NGFR (Fig. 13C,D) . More caudally, dual-stained sections revealed numerous trkA/ChAT-ir ( > 80%) (Fig. 13B ) and trkA/p75 NGFR-ir (> 95%) (Fig. 13E,F) neurons within the nucleus basalis. In the brainstem, the cholinergic neurons of the pedunculopontine and lateral dorsal tegmental nuclei were trkA and p75 NGFR immunonegative. However, trkA and p75 NGFR colocalized within the neurons of the mesencephalic nucleus of the fifth nerve.
Colocalization of trkA and serotonin
As described above, numerous small round trkA-ir neurons were visualized within the brainstem raphe nuclei. In order to determine the transmitter phenotype of these perikarya, we performed dual-immunohistochemical experiments using DAB as a chromogen for serotonin (brown reaction product) and BDHC for trkA (granular blue-black precipitate). Analysis of the dual-stained sections revealed that of the serotonergic neurons of the raphe nuclei 45% coexpressed trkA immunoreactivity ( Fig. 13G,H ; Table 1 ). The majority of these dual-labeled neurons were seen in the raphe median, obscurus, and magnus nuclei (Fig. 13G,H) .
Pan-trk-immunoreactive neurons in rat and monkey central nervous system
Sections immunostained with the pan-trk antibody revealed labeled neurons within all regions which displayed trkA imrnunoreactivity in the rat (Table 1 ). In addition, this pan-trk antibody also stained neurons within the hypothalamic arcuate and supraoptic nuclei (Fig. 14) , inferior and superior colliculus, ventral tegmental area of T'sai, substantia nigra, and the cerebellar Purkinje cells (Fig. 15) . We have previously shown that this pan-trk antibody stains neurons within the monkey striatum and cholinergic basal forebrain and in press a and b) similar to that seen in the present study. In addition, brainstem and spinal cord sections from these monkeys stained with the pan-trk antibody displayed a pattern of immunoreactivity similar to that described in the rat (present study). For example, numerous pan-trk-ir neurons were seen within the rat and monkey raphe nuclear complex (Fig. IS) , and the substantia gelatinosa of the spinal cord exhibited pan-trk-ir fibers (Fig. 17) .
DISCUSSION
The present investigation employing an antibody directed against the extracellular domain of trkA, a signal transducing NGF receptor, revealed a widespread distribution of immunoreactive perikarya and fibers throughout the rat central nervous system. TrkA-immunoreactive neurons were observed within the olfactory tubercle, nucleus accumbens, striaturn, septal/diagonal band complex, nucleus basalis, thalamic paraventricular and reuniens nuclei, periventricular hypothalamus, interpeduncular nucleus, mesencephalic and oralis portion of the spinal trigemimal nucleus of the fifth nerve, dorsal nucleus of the lateral lemniscus, prepositus hypoglossal nucleus ventral cochlear nucleus, ventral lateral tegmentum, medial vestibular nucleus, solitarius tract nucleus, and raphe nuclei. Although several in situ hybridization studies have reported that neurons within these regions express mRNA for trkA (Holtzman et al., 1992; Merlio et al., 1992; Gibbs and Pfaf€, 19941 , localization of the trkA protein using immunohistochemistry is limited to the cholinergic basal forebrain neurons of rats (Steininger et al., 1993) and monkeys and in press a and b). Sections stained with the pan-trk antibody reveal immunoreactive neurons in all nuclear regions labeled with the RTA antisera (present study) as well as within the arcuate, supraoptic and supramammilary hypothalamic nuclei, inferior and superior colliculi, substantia nigra, and ventral tegmental area of T'sai. Although trkA mRNA has not been reported in these brainstem areas (Gibbs and P f d , 19941 , several studies indicate that these regions express either trkB or trkC mRNA (Merlio et al., 1992; Seroogy and Gall, 1994; Seroogy et al., 1994; Altar et al., in press ). Dual immunohistochemical experiments demonstrated that within the septal/diagonal band complex virtually all trkA neurons (>95%) coexpressed both ChAT and p75 NGFR. In contrast, within the nucleus basalis trkA colocalized only with 80% of the cholinergic perikarya while greater than 95% of these trkA neurons coexpressed the p75 NGFR (see Steininger et al., 1993) . A recent study combining in situ hybridization detection of trkA mRNA with immunohistochemical staining for the p75 NGFR revealed a similar degree of colocalization within the rat basal forebrain (Gibbs and Pfaff, 1994) . The close correspondence between the expression of the trkA and low-affinity p75 NGFR within the basal forebrain is not an unexpected finding since multiple lines of evidence have demonstrated that NGF provides trophic influences for cholinergic basal forebrain neurons (see review in Hefti et al., 1989) . As part of this process, both the trkA and p75 NGF receptors are believed to be synthesized within the perikarya of cholinergic basal forebrain neurons. Our trkA-immunohistochemical findings together with the detection of trkA mRNA (Gibbs and Pfaff, 1994) within these neurons confirm this process in the rodent brain. In fact, retrogradely transported NGF has been immunohistochemically visualized within basal forebrain consumer neurons in rats, monkeys, and humans . It has been postulated that both trkA and p75 NGF receptors are transported in an anterograde fashion to reach target regions of basal forebrain neurons (see Jing et al., 1992 , for discussion) such as the hippocampus and cerebral cortex (Mesulam et al., 1983) . Then the endogenous neurotrophin binds to the trkA receptor, and is retrogradely transported to basal forebrain somata where the activated protein tyrosine kinase exerts trophic actions. Potentially, the low-affinity p75 receptor facilitates kinases of NGF to the trkA and/or the retrograde transport of the NGFitrkA complex from basal forebrain target regions to the NGF consumer perikarya within the basal forebrain (Jing et al., 1992) . It is interesting to note that although virtually all ChAT-containing neurons were immunopositive for p75 NGFR, only about 80% coexpressed trkA within the nucleus basalis. This suggests that a subpopulation of cholinergic basal forebrain neurons may potentially not be responsive to the trophic effects of NGF, but may respond instead to another neurotrophin (Hempstead et al., 1989; Jing et al., 1992) .
TrkA immunoreactivity was also observed in many nonbasal forebrain regions. In this regard, numerous trkA-ir neurons were observed within the olfactory tubercle, nucleus accumbens, striatum, thalamic paraventricular and reuniens nuclei, periventricular hypothalamus, interpeduncular nucleus, mesencephalic and oralis portion of the spinal trigeminal nucleus of the fifth nerve, dorsal nucleus of the lateral lemniscus, prepositus hypoglossal nucleus ventral cochlear nucleus, ventral lateral tegmentum, medial vestibular nucleus, solitarius tract nucleus, and raphe nuclei. As mentioned previously, these regions also express trkA mRNA (Gibbs and Pfaff, 1994) . Moreover, virtually all of these non-basal forebrain trkA-ir regions expressed p75 mRNA or protein under normal or altered physiological conditions (present study data not shown: Kordower et al., 1988; Yan and Johnson, 1988; Pioro and Cuello, 1990a,b; Mufson et al., 1992) . Thus, there appears to be a good correlation between the regional coexpression of trkA and p75 NGFR, suggesting that both NGF receptors may play unique roles underlying the biological activity of NGF in the brain. However, biological evidence for a physiological effect of NGF on any of these regions has yet to be clearly defined. It is interesting to note that there are regions such as the thalamic paraventricular and reuniens nuclei which express the protein (present study) and mRNA for trkA (Gibbs and Pfaff, 1994) but do not display the p75 NGFR or high-affinity NGF-binding sites. It is possible that these regions contain extremely low levels of p75 NGFR which are undetectable under normal conditions. However, during stressful physiological events these trkA-ir neurons can express increased levels of p75 NGFR. For example, it is known that following peripheral nerve damage that neurons of the hypoglossal, facial, and spinal cord express high levels of p75 NGFR (Armstrong et al., 1991; Saika et al., 1991; Koliatsos et al., 1991; Hayes et al., 1992; Rende et al., 1992; Kordower et al., 1992) . It remains to be determined whether NGF has any effect on these thalamic trkA-ir neurons.
Alternatively, the presence of trkA immunoreactivity within cholinergic striatal neurons (present study; Kordower et al., 1994 and in press a and b) lends support to the notion that neurotrophins such as NGF can act in a local manner (Lu et al., 1989; Mufson et al., 1991b; Miranda et al., 1993) in addition to the classic target-derived fashion proposed for basal forebrain function (see review: Eide et al., 1993) . Since the trkA receptor mediates the biological activity of NGF (see reviews : Bothwell, 1991; Ebendal, 1992; Parada et al., 1992) , the presence of trkA receptors alone within neurons suggests a functional role for NGF within these cells. Indeed, several studies have demonstrated that cholinergic striatal neurons are sensitive to the trophic effects of NGF. Infusion of NGF into neonatal rat pups increases ChAT activity within the striatum (Mobley et al., 1985) . Striatal neurons during development express the low-affinity NGF receptor in rodents (Yan and Johnson, 1988; Lu et al., 1989) and humans (Kordower and Mufson, 19931 , and striatal neurons express the high-affinity trkA receptor during rodent development (Miranda et al., 1993; Ringstedt et al., 1993) and in adulthood (Steininger et al., 1993) . In the case of the striatum, it is likely that NGF acts within the striatum through interactions with the trkA receptor. In this regard, infusions of NGF (Davies and Beardsall, 1992; in press a-c) or grafting of NGF secreting cells into the striatum (Schumacher et al., 1991; Frim et al., 1993) protect cholinergic interneurons from the destructive effects of mitochondrial dysfunction or excitatory amino acid administration. Furthermore, cholinergic striatal neurons hypertrophy in response to grafts of NGF secreting cells in normal rats (Chen et al., in press ). Interestingly, trkA-ir striatal cholinergic neurons in the rat (present study), adult nonhuman primate (Kordower et al., 1988 and in press a and b), and human do not express the low-affinity p75 NGF receptor under normal physiological conditions. Therefore, it appears that the trophic effects of NGF in vivo can occur without the presence of the low-affinity p75 NGF receptor. However, it is also possible that the p75 NGF receptor is present at low levels in the striatum and thus contributes to the biological action of NGF.
The present immunohistochemical study, as well as in situ hybridization (Gibbs and Pfaff, 1994) experiments, demonstrate that the neurons of the raphe nuclear complex contain the protein and mRNA for trkA. These investigations revealed trkA perikarya primarily within raphe magnus, median, and obscurus. We also found trk-ir neurons within the monkey raphe complex. Our dual-immunohistochemical staining demonstrated that 45% of the total serotonin containing neuronal population within the raphe nuclear complex coexpressed trkA. Similar to neurons of the cholinergic basal forebrain, perikarya of the raphe nuclei project in a widespread fashion to the hippocampus and cerebral cortex (Nieuwenhuys, 1985) and express trkB and trkC (Merlio et al., 1992) . Presently, there is no experimental evidence to suggest that NGF acts directly on serotonergic neuronal cell types. However, initial studies indicate that BDNF, which binds preferentially with trkB (Berkmeier et al., 1991; Bothwell, 19911 , can influence serotonin activity within the midbrain. For example, midbrain infusions of BDNF produce analgesia and augment serotonin turnover locally in descending and ascending pathways Martin-Iverson et al., 1994 1.
In contrast, infusions of NT-3 into the midbrain have very little effect on nociception and serotonin metabolism (Siuciak et al., 19941 , which may be due the expression of different forms of truncated trkC receptors within this region. The functional significance of multiple expression of trk receptors within the same region and their ability to bind various neurotrophins within the CNS remain to be fully evaluated.
In the present investigation the distribution of specific trkA labeling was compared to that visualized using a pan-trk antibody which preferentially stains trkA (Steininger et al., 1993; Kordower et al., 1994 and in press a and b) and probably trkB and trkC (Oncogene Science, MA). The pan-trk antibody labeled neurons within all regions seen in the present study using the specific trkA antisera as well as perikarya within the arcuate, supramammilary, supraoptic hypothalamic nuclei, hilar and CA3 regions of the hippocampus, inferior and superior colliculus, substantia nigra, ventral tegmental area of T'sai and cerebellar Purkinje cells. Purkinje cells of the cerebellum also express the protein and mRNA for p75 NGFR (Pioro and Cuello, 1990b; Mufson et al., 1991b) . In the present study, all regions which contained pan-trk but not trkA immunoreactivity have been reported to express either the trkB protein (Zhou et al., 1993) or mRNA for trkB and trkC (Merlio et al., 1992; Kokaia et al., 1993; Altar et al., 1994) . These findings suggest that these regions may be responsive to the neurotrophins BDNF and NT-3. Indeed, infusions of human BDNF into the striatum of rats retrogradely labeled neurons within the pars compacta of the substantia nigra and the ventral tegmental area of T'sai , which express mRNA for BDNF (Seroogy et al., 1994) and trkB (Merlio et al., 1992; Kokaia et al., 1993; Altar et al., in press) . Further studies are needed to fully clarify the role that the various trk receptors play in the signal transduc-tion of the family of NGF-related neurotrophins throughout the CNS.
TrkA-ir fibers were seen within the glomerular layer of the olfactory bulb, cingulate cortex, septum, vertical and horizontal limbs of the diagonal band, endopiriform nucleus, thalamus, hilar region of the hippocampus, subiculum, entorhinal cortex, interpeduncular nucleus, periaqueductal grey, midline raphe, and substantia gelatinosa of the spinal cord. The precise cells of origin for these trkA projection systems remain to determined. Studies utilizing retrograde transport of horseradish peroxidase combined with immunohistochemistry suggest that many of these fiber systems arise from cholinergic basal forebrain or serotonergic raphe neurons. For example, immunohistochemical staining for cholinergic cells with retrograde neuronal labeling techniques has demonstrated that the olfactory bulb is innervated by cholinergic perikarya of the horizontal limb of the diagonal band (Mesulam et al., 1983) . Since we have shown that virtually all cholinergic neurons of the horizontal limb of the diagonal band colocalize trkA, then at least a portion of this projection is most likely derived from these trkA-ir neurons. The trkA-ir fibers seen within the hippocampal complex may arise, at least in part, from trldicholinergicpositive cells located within the septum and vertical limb of the diagonal band (Mesulam et al., 1983) . TrkA-ir fibers seen within the thalamus, interpeduncular nucleus, midbrain periaqueductal gray, and raphe complex may arise from neurons of the ventral ascending serotonergic pathway of the raphe (see review by Nieuwenhuys, 1985) , which contain the protein (present study) and mRNA (Gibbs and Pfaff, 1994) for trkA. In addition, these trkA/serotonergicimmunopositive neurons may also, in part, give rise to the cells of origin for a portion of the trkA-ir fibers observed within the olfactory bulb, septum and diagonal band, cingulate and entorhinal cortex, as well as the substantia gelatinosa of the spinal cord (Bowker et al., 1981; Nieuwenhuys, 1985) .
Overall, using a polyclonal antibody raised against the extracellular domain of the trkA receptor we demonstrated a widespread distribution of trkA-ir perikarya and fibers throughout the rat CNS. Thus, these regions contain neurons which can potentially transduce the signal for NGF and mediate the biological effects of this neurotrophin. Within the basal forebrain, virtually all trkA neurons also expressed the p75 low-affinity NGF receptor, whereas not all cholinergic perikarya expressed trkA. TrkA-ir neurons in any other forebrain or brainstem region, with the exception of the mesencephalic nucleus of the fifth nerve, failed to express both p75 NGFR and trkA receptors. Furthermore, the expression of trkA throughout the central neural axis suggests that this receptor may play a role in signal transduction mechanisms related to NGF (or other as yet unknown trophic factors) not only within the cholinergic basal forebrain but in non-cholinergic systems.
Finally, it has also been hypothesized that altered trophic support may underlie the pathophysiology of neurodegeneration seen in Alzheimer's disease (AD), Parkinson's disease, and amyotrophic lateral sclerosis (Appel, 1981; Hefti, 1986; Hefti et al., 1989; Kordower and Mufson, 1989) . Preliminary investigations in our laboratory using an antibody which recognizes endogenous NGF have revealed a reduction in NGF-like immunoreactivity within remaining basal forebrain neurons in AD (Mufson et al., 1993b . In AD, NGF levels in basal forebrain target regions have been reported to remain unchanged (Goedert et al., 1986) or increased (Crutcher et al., 1993) in cortex. Similarly, levels of the low-affinity p75 NGF receptor has been discribed as either stable or elevated in AD (Higgins and Mufson, 1989; Ernfors et al., 1990a,b) . This suggests that there is impaired internalization and/or retrograde transport of targetderived NGF associated with a defect in the complexing of this trophin with its high-affinity signal transducing trkA receptor in AD. Perhaps, compounds could be developed that regulate either endogenous neurotrophin production or the signal transduction mechanisms under their regulation. In this regard, pharmacological use of trk receptors could have beneficial effects on the multiple neuronal systems disrupted in AD.
